Cramer Remix: Another speculative biotech with tremendous upside By: CNBC.com News September 19, 2016 at 19:08 PM EDT Jim Cramer eyed the biotechs after Sarepta Therapeutics rally, and found another attractive spec that could boost portfolios. Read More >> Related Stocks: Coach